Andrew Callos

Companies

• CytokineticsChief Commercial Officer Mar 18, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CCytokinetics CYTK58,555 shares²$3.7M at $62.76Aug 31, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 31, 2026Sold 10,000 shares at $70.24 of Cytokinetics²
• Aug 31, 2026Exercised options 10,000 shares at $23.26 of Cytokinetics²
• Jul 30, 2026Sold 14,000 shares at $79.88 of Cytokinetics³
• Jul 30, 2026Exercised options 14,000 shares at $23.26 of Cytokinetics³
• Jul 1, 2026Sold 15,000 shares at $85.80 of Cytokinetics⁴
• Jul 1, 2026Exercised options 15,000 shares at $23.26 of Cytokinetics⁴
• Jun 1, 2026Sold 15,000 shares at $74.08 of Cytokinetics⁵
• Jun 1, 2026Exercised options 15,000 shares at $23.26 of Cytokinetics⁵
• May 5, 2026Sold 11,333 shares at $77.25 of Cytokinetics⁶
• May 5, 2026Exercised options 11,333 shares at $39.13 of Cytokinetics⁶
• May 1, 2026Sold 15,857 shares at $65.00 of Cytokinetics⁷
• May 1, 2026Exercised options 15,857 shares at $37.63 of Cytokinetics⁷
• Apr 30, 2026Sold 15,000 shares at $63.26 of Cytokinetics⁸
• Apr 30, 2026Exercised options 15,000 shares at $23.26 of Cytokinetics⁸
• Apr 15, 2026Sold 7,449 shares at $66.02 of Cytokinetics⁹
• Mar 31, 2026Sold 3,639 shares at $65.00 of Cytokinetics¹⁰
• Mar 18, 2026Sold 1,930 shares at $62.07 of Cytokinetics¹¹
• Mar 17, 2026Sold 2,916 shares at $62.15 of Cytokinetics¹²
• Mar 17, 2026Sold 5,626 shares at $62.15 of Cytokinetics¹²
• Mar 16, 2026Sold 1,709 shares at $61.03 of Cytokinetics¹³
• Mar 15, 2026Granted 13,320 shares of Cytokinetics¹⁴
• Mar 15, 2026Granted 20,646 shares of Cytokinetics¹⁴
• Mar 9, 2026Sold 2,582 shares at $60.72 of Cytokinetics¹⁵
• Mar 5, 2026Exercised options 15,000 shares at $23.26 of Cytokinetics¹⁶
• Mar 5, 2026Sold 11,000 shares at $61.88 of Cytokinetics¹⁶